JP2025532676A5 - - Google Patents
Info
- Publication number
- JP2025532676A5 JP2025532676A5 JP2025517344A JP2025517344A JP2025532676A5 JP 2025532676 A5 JP2025532676 A5 JP 2025532676A5 JP 2025517344 A JP2025517344 A JP 2025517344A JP 2025517344 A JP2025517344 A JP 2025517344A JP 2025532676 A5 JP2025532676 A5 JP 2025532676A5
- Authority
- JP
- Japan
- Prior art keywords
- ngf
- pharmaceutical composition
- use according
- mutant protein
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22197562.6 | 2022-09-23 | ||
| EP22197562.6A EP4342485A1 (en) | 2022-09-23 | 2022-09-23 | Ngf for the treatment of spasticity |
| PCT/EP2023/076387 WO2024062135A1 (en) | 2022-09-23 | 2023-09-25 | Ngf for the treatment of spasticity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025532676A JP2025532676A (ja) | 2025-10-01 |
| JP2025532676A5 true JP2025532676A5 (https=) | 2026-04-28 |
Family
ID=83438536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025517344A Pending JP2025532676A (ja) | 2022-09-23 | 2023-09-25 | 痙縮治療のためのｎｇｆ |
Country Status (7)
| Country | Link |
|---|---|
| EP (2) | EP4342485A1 (https=) |
| JP (1) | JP2025532676A (https=) |
| CN (1) | CN120239610A (https=) |
| AU (1) | AU2023345675A1 (https=) |
| CA (1) | CA3266315A1 (https=) |
| IL (1) | IL319010A (https=) |
| WO (1) | WO2024062135A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026022244A1 (en) | 2024-07-23 | 2026-01-29 | Chiesi Farmaceutici S.P.A. | A polypeptide for use in the therapeutic management of acute ischaemic stroke |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2213861T3 (es) | 1998-10-09 | 2004-09-01 | Scil Proteins Gmbh | Procedimiento de obtencion de ngf-beta activa. |
| CN1112215C (zh) * | 1999-12-28 | 2003-06-25 | 潘晓东 | 神经生长因子在治疗有机溶剂中毒性周围神经病中的用途 |
| EP2907521B1 (en) | 2011-12-19 | 2017-11-22 | Wacker Chemie AG | Novel prongf mutants and uses thereof in the production of beta-ngf |
| CN109153709B (zh) * | 2016-03-18 | 2022-05-27 | 舒泰神（北京）生物制药股份有限公司 | 神经生长因子突变体 |
| IT201600112420A1 (it) * | 2016-11-08 | 2018-05-08 | Univ Cattolica Del Sacro Cuore | Nuova formulazione per via intranasale |
| US12378293B2 (en) | 2018-04-27 | 2025-08-05 | Chiesi Farmaceutici Spa | Production of nerve growth factor (NGF) and of muteins thereof |
| PT4031117T (pt) * | 2019-09-17 | 2024-10-25 | Chiesi Farm Spa | Mutante do ngf para utilização no tratamento ou prevenção de distúrbios oftálmicos |
| TW202229322A (zh) * | 2020-11-19 | 2022-08-01 | 大陸商舒泰神（北京）生物製藥股份有限公司 | 長效神經生長因數多肽及其用途 |
-
2022
- 2022-09-23 EP EP22197562.6A patent/EP4342485A1/en not_active Withdrawn
-
2023
- 2023-09-25 JP JP2025517344A patent/JP2025532676A/ja active Pending
- 2023-09-25 WO PCT/EP2023/076387 patent/WO2024062135A1/en not_active Ceased
- 2023-09-25 AU AU2023345675A patent/AU2023345675A1/en active Pending
- 2023-09-25 EP EP23777211.6A patent/EP4590324A1/en active Pending
- 2023-09-25 IL IL319010A patent/IL319010A/en unknown
- 2023-09-25 CA CA3266315A patent/CA3266315A1/en active Pending
- 2023-09-25 CN CN202380067388.4A patent/CN120239610A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0694307B1 (en) | Atopic disease remedy | |
| EP0614369B1 (en) | Pharmaceutical dipeptide compositions and methods of use thereof | |
| US5789384A (en) | Pharmaceutical dipeptide compositions and methods of use thereof | |
| US20090156484A1 (en) | Use of Transferrins for Treating Destructive Inflammation of Mucous Membrane | |
| JP2961709B2 (ja) | 呼吸器系疾患の治療方法および治療用薬剤組成物 | |
| JP3250804B2 (ja) | 治療用ペプチド | |
| JP2025532676A5 (https=) | ||
| JP2025166032A (ja) | 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 | |
| AU668088B2 (en) | Pharmaceutical dipeptide compositions and methods of use thereof | |
| JP2025525989A5 (https=) | ||
| US20210401880A1 (en) | Pharmaceutical Composition For Preventing Or Treating Obesity, Containing CYCLO(HIS-PRO) As Active Ingredient | |
| CN1917898B (zh) | 用于治疗间质肺部感染的血管活性肠肽的生物活性物质 | |
| JP2007119497A (ja) | インターフェロン−ガンマスティミュレーター含有医薬組成物 | |
| Myers et al. | Potentiation of human interferon production by superinduction | |
| CA2323213C (en) | Treatment of respiratory disease and otitis media | |
| RU2025110129A (ru) | Ngf для лечения спастичности | |
| KR100302994B1 (ko) | 약독화된비면역원성폭스바이러스또는파라폭스바이러스로부터멀티포텐트파라폭스면역유발인자의약제로서이용하는새로운적용 | |
| EP0080032A2 (en) | Pharmaceutical preparation for treating herpetic lesions | |
| JP2022518527A5 (https=) | ||
| AU1392301A (en) | Interferon gamma for the treatment of asthma | |
| CZ234098A3 (cs) | Farmaceutický výrobek | |
| CA2687013C (en) | Method and composition for treatment and prevention of broad spectrum virus ailments | |
| JP4166955B2 (ja) | ウイルス疾患を処置するためのビュープロピオン | |
| CN112656936B (zh) | 免疫细胞因子白介素-22在制备抗抑郁药物中的应用 | |
| CN104510752B (zh) | 紫檀烷苷的医药用途 |